Last reviewed · How we verify
Dummy infusion
Dummy infusion is a treatment that involves the administration of a dummy substance to mimic the effects of a real infusion.
Dummy infusion is a treatment that involves the administration of a dummy substance to mimic the effects of a real infusion. Used for Treatment of symptoms in patients with a known or suspected diagnosis of a serious medical condition.
At a glance
| Generic name | Dummy infusion |
|---|---|
| Also known as | Placebo |
| Sponsor | Imunon |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action of dummy infusion is unknown, but it is thought to work by causing a placebo effect in patients. This can lead to improvements in symptoms and quality of life. However, the effects of dummy infusion are short-lived and do not provide any actual therapeutic benefit.
Approved indications
- Treatment of symptoms in patients with a known or suspected diagnosis of a serious medical condition
Common side effects
- Nausea
- Vomiting
- Headache
Key clinical trials
- A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy (PHASE3)
- A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) (PHASE3)
- A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP (PHASE3)
- A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis (PHASE2)
- Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing (PHASE4)
- Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid (PHASE3)
- A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis (RRMS) (PHASE3)
- Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dummy infusion CI brief — competitive landscape report
- Dummy infusion updates RSS · CI watch RSS
- Imunon portfolio CI